about
Development and validation of a liquid chromatography-mass spectrometry assay for the determination of opiates and cocaine in meconium.Development and validation of a high-performance liquid chromatography-mass spectrometry assay for determination of amphetamine, methamphetamine, and methylenedioxy derivatives in meconium.Development and validation of a high-performance liquid chromatography-mass spectrometry assay for methylxanthines and taurine in dietary supplements.Application of a validated high-performance liquid chromatography-mass spectrometry assay to the analysis of m- and p-hydroxybenzoylecgonine in meconium.Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.Breast Milk and Hair Testing to Detect Illegal Drugs, Nicotine, and Caffeine in Donors to a Human Milk Bank.Liquid chromatography/electrospray ionization tandem mass spectrometry assay for determination of nicotine and metabolites, caffeine and arecoline in breast milk.Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma.Quantification of the plant-derived hallucinogen Salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking.Assessment of unsuspected exposure to drugs of abuse in children from a Mediterranean city by hair testing.Identification and quantification of psychoactive drugs in whole blood using dried blood spot (DBS) by ultra-performance liquid chromatography tandem mass spectrometry.Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi.Identification and quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid glucuronide (THC-COOH-glu) in hair by ultra-performance liquid chromatography tandem mass spectrometry as a potential hair biomarker of cannabis use.Usefulness of sweat testing for the detection of methylphenidate after fast- and extended-release drug administration: a pilot study.Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol.Assay of gamma-glutamylcysteine synthetase activity in Plasmodium berghei by liquid chromatography with electrochemical detection.Sweat testing for the detection of atomoxetine from paediatric patients with attention deficit/ hyperactivity disorder: application to clinical practice.Simultaneous determination of zidovudine and nevirapine in human plasma by RP-LC.Assessment of prenatal exposure to ethanol by meconium analysis: results of an Italian multicenter study.Quantification of arecoline (areca nut alkaloid) in neonatal biological matrices by high-performance liquid chromatography/electrospray quadrupole mass spectrometry.New vesicular ampicillin-loaded delivery systems for topical application: characterization, in vitro permeation experiments and antimicrobial activity.A rapid and simple procedure for the determination of cannabinoids in hemp food products by gas chromatography-mass spectrometry.High performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of vardenafil, sildenafil, tadalafil, testosterone and local anesthetics in cosmetic creams sold on the Internet web sites.Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".Liquid chromatography-electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices.Liquid chromatography with tandem mass spectrometric detection for the measurement of ethyl glucuronide and ethyl sulfate in meconium: new biomarkers of gestational ethanol exposure?Liquid chromatography-tandem mass spectrometry for fatty acid ethyl esters in meconium: assessment of prenatal exposure to alcohol in two European cohorts.High-performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of non-allowed substances in cosmetic products for preventing hair loss and other hormone-dependent skin diseases.Ultrasensitive detection of nicotine and cotinine in teeth by high-performance liquid chromatography/tandem mass spectrometry.3,4-methylenedioxymethamphetamine (MDMA) intoxication in an infant chronically exposed to cocaine.Development and validation of a gas chromatography-mass spectrometry assay for opiates and cocaine in human teeth.Determination of arecoline (areca nut alkaloid) and nicotine in hair by high-performance liquid chromatography/electrospray quadrupole mass spectrometry.Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety.On-site screening and GC-MS analysis of cocaine and heroin metabolites in body-packers urine.Development and validation of a liquid chromatography-mass spectrometry assay for hair analysis of methylphenidate.Are false-positive phencyclidine immunoassay instant-view multi-test results caused by overdose concentrations of Ibuprofen, metamizol, and dextromethorphan?Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) for determination of GHB, precursors and metabolites in different specimens: Application to clinical and forensic cases.Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption.
P50
Q33427412-16122C2E-E364-40C6-999A-A0CC9E5F8DC9Q33431437-C046768B-5DF0-45B7-9E1C-CC8453546E6AQ33433011-C00ACE37-720F-4CCC-863A-87E08B19B4A4Q33433324-AFC7A261-B233-4BB3-9A4C-739270A1E02CQ33439214-65116AC8-C4F8-4F5A-88CC-D58C8262834DQ33458250-B017E22E-8C5A-460A-93B7-A94FF45539B9Q34005246-62C25C34-91DD-4822-B58B-CFCCCDAAE9CAQ34099596-5CC0C4A1-F51A-42C5-9EF6-F52A1117DC9DQ34421288-95BB8495-43E2-4EE9-8A86-F037495ED8A2Q37623087-68F8070C-E419-49E4-A58F-0430AE0F180CQ39731756-2E7781CD-E51F-4919-88B3-5A3A366A4B45Q40867191-6A29CCE4-0C91-4639-9C94-496DA83E1080Q41468301-4EE86381-4C8C-402E-8635-FDCCFF363F1BQ43036776-AD7023EA-43A6-4495-AC37-BF5D07C6743AQ43067976-72081750-9215-431C-8AEB-1E275DCD8DEEQ43185673-6BDED13E-CE4D-4AA8-AAEA-BB08AB927148Q43199052-7AA6D98C-A827-4810-8CC8-2FD9EA1D1DAAQ43620229-475A8EE2-B18E-4A63-941A-DCCE850C9016Q43943982-8785FE9F-23D2-432E-99CE-637B45CFAD58Q44058063-A19FC6DA-DEED-4C0C-BE3C-19437DC61B0EQ44259327-0D1CFDAB-9C23-42DB-9ACD-DB129B30FC48Q44546158-22ED5992-AA63-4AC6-AB4C-61481C13B99FQ44794594-1D61D830-1C06-4E62-AF65-00FDF9F0CA42Q45202649-F3A9ACB4-1B7A-4B1D-859C-9D257A7F79B7Q45962021-9FAA6E2A-4742-434D-A828-E1071063E5E1Q46155561-45D12D92-EACB-4158-ACB7-F36CD83EB677Q46178466-F43A29F8-E7F9-4F64-A199-CB06B7BDBA54Q46213576-E4FF727C-DA32-4DAA-84CC-20C5FE875166Q46373027-D1263EB1-5D2F-4A58-9D27-BC123C730EECQ46462074-DEA5D35C-CFD6-405F-AC7E-C5892E492E06Q46469850-6D5C444A-6891-465F-A752-28FAFDA57FF9Q46619029-1B4F1407-886B-408E-9070-ECB6CC3FBB44Q46631951-37AE9234-B08C-4694-86A2-F91A9553D0FDQ46782704-9D6AF3CC-ECE9-4DB6-8020-B5F91035BE77Q46808222-BE4389E0-FB06-4E30-9880-AC0B9E4ADFCDQ46829508-464F9291-9643-4AA5-865C-855BF72E00DFQ46916325-2BC7DA0F-8683-46A7-8079-E80E4427083BQ46979467-D74C8D7D-7904-4918-80B4-6F3009B6862DQ47339214-0A627B14-2060-4E89-A8CA-1A9E5F5F119EQ47620663-3092A270-66EC-4B44-9AAB-7233E02ABA9D
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Emilia Marchei
@ast
Emilia Marchei
@en
Emilia Marchei
@es
Emilia Marchei
@sl
type
label
Emilia Marchei
@ast
Emilia Marchei
@en
Emilia Marchei
@es
Emilia Marchei
@sl
prefLabel
Emilia Marchei
@ast
Emilia Marchei
@en
Emilia Marchei
@es
Emilia Marchei
@sl
P1053
K-6602-2016
P106
P1153
6506903572
P21
P31
P3829
P496
0000-0002-7158-6032